Combination of Myelin Basic Protein Gene Polymorphisms with HLA-DRB1*1501 in Iranian Patients with Multiple Sclerosis

被引:1
|
作者
Nejati, Parham [1 ]
Attar, Marzieh [1 ]
Rahimian, Maryam [1 ]
Fathi, Davood [2 ]
Shahbazi, Majid [1 ]
机构
[1] Golestan Univ Med Sci, Med Cellular & Mol Res Ctr, Azar Univ Hosp 5, Gorgan, Iran
[2] Golestan Univ Med Sci, Dept Neurol, Azar Univ Hosp 5, Gorgan, Iran
关键词
MBP; MS; PCR; Polymorphism; VNTR; SUSCEPTIBILITY; ASSOCIATION; IDENTIFICATION; EXPRESSION; HAPLOTYPES; ALLELES; MS;
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: Multiple sclerosis (MS), as a multifactorial autoimmune disease with complex genetic basis, causes demyelination in the central nervous system via cytokine responses to myelin antigens. Myelin basic protein (MBP) is the main protein component of the myelin sheath. HLA-DRB (human leukocyte antigen-DR beta) alleles, particularly HLA-DRB1*1501, may be of significance in the pathogenesis of MS. Objective: To examine the association of HLA-DRB1*1501 alleles and MBP VNTR (variable number tandem repeat) polymorphism with the MS susceptibility in Iranian population. Methods: Genomic DNA was extracted from peripheral blood. The alleles were determined by the Polymerase Chain Reaction (PCR) method in 259 MS patients and 312 healthy control individuals and analyses were carried out using Fisher's exact test. Results: The frequencies of MBP VNTR genotypes (AA, AB and BB) were 47%, 42% and 11% among patients, and 45%, 43% and 12% in control subjects, respectively. HLA-DRB1*1501 allele was more frequent among patients than healthy individuals (OR=1.65, P=0.0045). The frequency of allele A and genotype A/A was significantly higher among HLA-DRB1*1501 positive patients (61% and 32%) than controls (46% and 19%) (OR=1.88, P=0.0013; A/A vs. B/B: OR=5.09, P=0.0004). The two-locus analysis of the interaction between the MBP VNTR polymorphism and the HLA-DRB1 allele showed that the HLADRB1*1501/A haplotype was more frequent among MS patients than the healthy controls. Conclusion: The interaction between the HLADRB1*1501 allele and MBP gene may be considered as a predisposing factor in the development and pathogenesis of MS in the case of gene-gene interaction.
引用
收藏
页码:231 / 239
页数:9
相关论文
共 50 条
  • [31] Epistatic interactions at HLA-DRB1 in Japanese patients with multiple sclerosis
    Isobe, N.
    Matsushita, T.
    Yamasaki, R.
    Ramagopalan, S.
    Kawano, Y.
    Nishimura, Y.
    Ebers, G.
    Kira, J. I.
    MULTIPLE SCLEROSIS, 2009, 15 (09): : S184 - S184
  • [32] HLA-DRB1*1501 and response to copolymer-1 therapy in relapsing-remitting multiple sclerosis
    Fusco, C
    Andreone, V
    Cappola, G
    Luongo, V
    Guerini, F
    Pace, E
    Florio, C
    Pirozzi, G
    Lanzillo, R
    Ferrante, P
    Vivo, P
    Mini, M
    Macrì, M
    Orefice, G
    Lombardi, ML
    NEUROLOGY, 2001, 57 (11) : 1976 - 1979
  • [33] HLA-DRB1 allelic frequencies in multiple sclerosis patients in Argentina
    Patrucco, Liliana B.
    Redal, Mariana
    Cristiano, Edgardo
    Larriba, Julian
    Argibay, Pablo
    MULTIPLE SCLEROSIS, 2008, 14 : S195 - S196
  • [34] HLA class I alleles tag HLA-DRB1*1501 haplotypes for differential risk in multiple sclerosis susceptibility
    Chao, Michael J.
    Barnardo, Martin C. N. M.
    Lincoln, Matthew R.
    Ramagopalan, Sreeram V.
    Herrera, Blanca M.
    Dyment, David A.
    Montpetit, Alexandre
    Sadovnick, A. Dessa
    Knight, Julian C.
    Ebers, George C.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (35) : 13069 - 13074
  • [35] HLA-DRB1 and disease outcome in multiple sclerosis
    Weatherby, SJM
    Thomson, W
    Pepper, L
    Donn, R
    Worthington, J
    Mann, CLA
    Davies, MB
    Fryer, MB
    Fryer, AA
    Boggild, MD
    Young, CA
    Jones, PW
    Strange, RC
    Ollier, WER
    Hawkins, CP
    JOURNAL OF NEUROLOGY, 2001, 248 (04) : 304 - 310
  • [36] HLA-DRB1 and disease outcome in multiple sclerosis
    S. J. M. Weatherby
    W. Thomson
    L. Pepper
    R. Donn
    J. Worthington
    C. L. A. Mann
    M. B. Davies
    A. A. Fryer
    M. D. Boggild
    C. A. Young
    P. W. Jones
    R. C. Strange
    W. E. R. Ollier
    C. P. Hawkins
    Journal of Neurology, 2001, 248 : 304 - 310
  • [37] HLA-DRB1 and month of birth in multiple sclerosis
    Ramagopalan, S. V.
    Link, J.
    Byrnes, J. K.
    Dyment, D. A.
    Giovannoni, G.
    Hintzen, R. Q.
    Sundqvist, E.
    Kockum, I.
    Smestad, C.
    Lic, B. A.
    Harbo, H. F.
    Padyukov, L.
    Alfredsson, L.
    Olsson, T.
    Sadovnick, A. D.
    Hillert, J.
    Ebers, G. C.
    NEUROLOGY, 2009, 73 (24) : 2107 - 2111
  • [38] HLA-DRB1 and prognosis of multiple sclerosis in France
    Yaouanq, J
    Drapier, S
    Leray, E
    Le Page, E
    Chaperon, J
    Edan, G
    MULTIPLE SCLEROSIS, 2005, 11 : S118 - S118
  • [39] HLA-DRB1 and multiple sclerosis in a spanish population
    Romero-Pinel, L.
    Pujal, J. M.
    Gubieras, L.
    Matas, E.
    Bau, L.
    Martinez-Yelamos, S.
    Arbizu, T.
    JOURNAL OF NEUROLOGY, 2009, 256 : S35 - S36
  • [40] Evidence for linkage disequilibrium between HLA-DRB1 gene and multiple sclerosis
    Yaouanq, J
    Semana, G
    Eichenbaum, S
    Quelvennec, E
    Roth, MP
    Clanet, M
    Edan, G
    ClergetDarpoux, F
    SCIENCE, 1997, 276 (5313) : 664 - 665